PE eyes investments in oncology drug manufacturers: 6 deals

Blackstone, HIG Capital and Nordic Capital are among the PE firms investing in the oncology drug market.

ByJohn R Fischer

20 June 2025•5 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Featured Europe North America UK US Western Europe Healthcare Top Stories